Lupus Trial News

Learn what’s happening in lupus clinical research – breaking news about new trials and study results.

Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment

June 1, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive results from a Phase 2 trial of its investigational agent deucravacitinib for the treatment of systemic lupus erythematosus (SLE). Deucravacitinib is a potentially first-in-class inhibitor of Tyrosine kinase 2 (TYK2), which regulates […]

Read More

Learn more about the world of clinical trials

Our video section will bring you informative and inspiring messages from people involved in different aspects of lupus clinical studies – patient participants, researchers, healthcare professionals and trial consultants.

We are the world’s leading private funder of lupus research. Our goal: improve treatments while advancing lupus research toward a cure.

We are the world’s leading private funder of lupus research. Our goal: improve treatments while advancing lupus research toward a cure.

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up